The ATP II guidelines provide updated, risk-stratified thresholds for initiating diet and pharmacological therapy to lower LDL cholesterol and reduce CHD risk.
Answers are grounded in this paper and cite their sources.
Updates lipid management protocols with risk stratification; extends prior guidelines for targeted CHD prevention.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ernst J. Schaefer (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: